In this study, we establish a rodent model of T2D, characterize the counterregulatory response to hypoglycemia and evaluate proof of concept and efficacy of the SSTR2 antagonists PRL-2903 and ZT-01 to prevent insulin-induced hypoglycemia. Here, SSTR2 is linked to type 2 diabetes mellitus.